Skip to content

HUAMI RHYTHM STUDY

Large-scale arrhythmia (atrial fibrillation) screening study on smart wearable devices

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036142
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrilation

Interventions

Gold Standard:ECG,24-hour AECG, Long-term AECG
Index test:HUAMI&#32
wist&#32
devices&#32
and&#32
ECG

Sponsors

HUAMI (Beijing) Health Technology Limited
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Aged >= 18 years; 2) Smartphones with iOS10 and above, or Android5.0 and above; 3) HUAMI wrist wearable device users who have read and agreed to the informed consent form pushed in the App.

Exclusion criteria

Exclusion criteria: 1. Due to any of the following conditions, both upper limbs cannot use the bracelet or watch to collect information: (1) Disability of both upper limbs; (2) Abnormal skin on the wrist; (3) Severe occlusive vascular disease of upper limbs; (4) Significant edema of upper limbs. 2. Those who have a pacemaker implanted.

Design outcomes

Primary

MeasureTime frame
atrial fibrillation ECG;Atrial fibrillation detection rate;positive predictive value;

Countries

China

Contacts

Public ContactYong Huo

Peking University First Hospital

yonghuo@263.com+86 010-83572283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026